Satsuma Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.22
/
50%
€6.30
Target price
31.12.24
€8.00
Performance (%)
-88.33%
End price
14.12.22
€0.74
Summary
This prediction ended on 14.12.22 with a price of €0.74. The BUY prediction by BiotechBee for Satsuma Pharmaceuticals Inc. performed very badly with a performance of -88.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Satsuma Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % | 53,46 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % | 72,28 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % | 63,08 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % | 60,40 % |
According to BiotechBee what are the pros and cons of Satsuma Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year